Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Influenza

Free Subscription 07.09.2026 3 Antimicrob Agents Chemother 2 Antiviral Res 1 Epidemiol Infect 1 J Infect Dis 2 J Virol 1 JAMA 3 Pediatrics 1 PLoS Comput Biol 1 PLoS Med 8 PLoS One 1 Proc Natl Acad Sci U S A 6 Vaccine 3 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. DE ANGELIS M, Gori Savellini G, Piselli E, Anichini G, et al
   Redox-sensitive factors as targets of thiol compounds to hinder SARS-CoV-2 replication and inflammatory response.
   Antimicrob Agents Chemother. 2026;70:e0051826.
   PubMed         Abstract available
   
   
2. JEENA N, Khan IA
   Targeting SARS-CoV-2 programmed -1 ribosomal frameshifting: structural dynamics and RNA-directed antiviral strategies.
   Antimicrob Agents Chemother. 2026;70:e0068726.
   PubMed         Abstract available
   
   
3. AVILA-PONCE DE LEON U, Esmaeili S, Owens K, Schiffer JT, et al
   Plasma concentrations of nirmatrelvir and molnupiravir required for inhibition of SARS-CoV-2 replication differ between rhesus macaques and humans.
   Antimicrob Agents Chemother. 2026 Aug 5:e0030726. doi: 10.1128/aac.00307.
   PubMed         Abstract available
   
   

   
   Antiviral Res

4. PU F, Guo Y, Pan X, Liu X, et al
   Dual-targeting engineered binding proteins block SARS-CoV-2 infection and complement activation.
   Antiviral Res. 2026;254:106515.
   PubMed         Abstract available
   
   
5. YURGELONIS I, Rai DK, Lee JT, Li Z, et al
   Antiviral activity of nirmatrelvir against contemporary SARS-CoV-2 variants.
   Antiviral Res. 2026;254:106517.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

6. NAQVI OH, Wendelboe AM, Beasley WH, Tyungu DL, et al
   Epidemiological characteristics of paediatric COVID-19 and influenza co-infections in the United States, 2020-2024 - CORRIGENDUM.
   Epidemiol Infect. 2026;154:e111.
   PubMed        
   
   

   
   J Infect Dis

7. ZHAO B, Zhang G, Wu J, Zhang W, et al
   Characterization of bronchiolitis and vaccine-induced enhanced respiratory disease in Syrian hamsters caused by respiratory syncytial virus infection.
   J Infect Dis. 2026 Mar 4:jiag136. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

8. BHAVSAR D, Civljak A, Bonnettaz B, Arunkumar GA, et al
   Broadly reactive antibodies against influenza B virus hemagglutinin neutralize and protect through distinct structural mechanisms.
   J Virol. 2026 Sep 4:e0080226. doi: 10.1128/jvi.00802.
   PubMed         Abstract available
   
   
9. LIU D, Zhang Y, Zhang M, Guo R, et al
   A neuraminidase-targeting nanobody as a therapeutic candidate against influenza A and B viruses.
   J Virol. 2026 Aug 31:e0087426. doi: 10.1128/jvi.00874.
   PubMed         Abstract available
   
   

   
   JAMA

10. SENERTH E, Sheikholeslamian SM, Sivakumaran K, Watson MA, et al
    Influenza Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season.
    JAMA. 2026 Sep 2. doi: 10.1001/jama.2026.18126.
    PubMed         Abstract available
    
    

    
    Pediatrics

11. CHAN OW, Cheng YT, Liu YH, Chou IJ, et al
    Anakinra in Severe RSV-Associated Autoinflammatory Encephalopathy With Delayed ADEM-Like Changes.
    Pediatrics. 2026;158:e2026076364.
    PubMed         Abstract available
    
    
12. PAYNE AB, Battan-Wraith S, Reese SE, Hathaway CA, et al
    Effectiveness of RSV Prevention Strategies in US Infants: 2024-2025.
    Pediatrics. 2026 Aug 4:e2026076089. doi: 10.1542/peds.2026-076089.
    PubMed         Abstract available
    
    
13. MIN J, Tam V, Jacoby SF, McDonald CC, et al
    Community Firearm Violence, Youth Depression, and Suicide Risk in Philadelphia: 2017-2024.
    Pediatrics. 2026;158:e2025075438.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

14. FREEDMAN AS, Nielsen BF, Saad-Roy CM, Grenfell BT, et al
    Economic factors promoting vaccine nationalism in the face of viral evolution.
    PLoS Comput Biol. 2026;22:e1014466.
    PubMed         Abstract available
    
    

    
    PLoS Med

15. ELIAS KM, Mitchell A, Stadler E, Schlub TE, et al
    Neutralising antibodies and protection from progression to severe COVID-19: A meta-analysis.
    PLoS Med. 2026;23:e1005230.
    PubMed         Abstract available
    
    

    
    PLoS One

16. ADAMCZYK G, Jablonski A, Nowakowski PT, Ptaszek RT, et al
    Theodicy perspective as an effect of the interpenetration of mental and religious issues during the COVID-19 pandemic in Poland.
    PLoS One. 2026;21:e0355379.
    PubMed         Abstract available
    
    
17. JUNGMANN SM, Garbe Huedo SF, Jacobs KAS, Pothorn NK, et al
    Mental load in women and mothers: Causes of distress, personality traits, and psychopathology.
    PLoS One. 2026;21:e0356255.
    PubMed         Abstract available
    
    
18. MOUNADI N, Nour H, El Kouali M, Samadi A, et al
    Repositioning antiviral phytoconstituents as broad-spectrum inhibitors of influenza A neuraminidase and human metapneumovirus fusion protein.
    PLoS One. 2026;21:e0348517.
    PubMed         Abstract available
    
    
19. HAWKES BA, Hollister J, Porter C, Lyski ZL, et al
    Age-specific humoral immune response to SARS-CoV-2: A comparative analysis of antibody levels in children and adults after vaccination with primary series or infection.
    PLoS One. 2026;21:e0356178.
    PubMed         Abstract available
    
    
20. AVSAR FN, Kilicaslan N, Sahutoglu T
    Comparative associations of Anakinra and Tocilizumab initiation with in-hospital mortality in severe COVID-19: A single-center sequential cohort study.
    PLoS One. 2026;21:e0357671.
    PubMed         Abstract available
    
    
21. SEEGERT N, Gaulin M, Chaiyakunapruk N, Navarro-Sanchez F, et al
    The impact of state- versus county-level mask mandates on economic activity during the COVID-19 pandemic.
    PLoS One. 2026;21:e0332243.
    PubMed         Abstract available
    
    
22. HARDY MJ, Williams CK, Ladman BS, Pitesky ME, et al
    Using high frequency GPS data to assess wintering goose proximity to commercial poultry facilities on the Delmarva peninsula for avian influenza risk management and surveillance.
    PLoS One. 2026;21:e0355415.
    PubMed         Abstract available
    
    
23. KOPP J, Spies Rodriguez DC, Kunzi L, Puhan MA, et al
    Physical activity in post-COVID-19 condition: A cross-sectional study.
    PLoS One. 2026;21:e0357465.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

24. KARADAKIC R, Keating NL, Barnett ML
    Interpreting vaccine-associated survival differences in immune checkpoint inhibitor therapy.
    Proc Natl Acad Sci U S A. 2026;123:e2621501123.
    PubMed         Abstract available
    
    

    
    Vaccine

25. MOHAMMED H, Andraweera P, Marshall HS
    A cohort study to assess the safety and coverage of COVID-19, influenza, and pertussis vaccine in Australian pregnant women.
    Vaccine. 2026;91:129081.
    PubMed         Abstract available
    
    
26. SHEN AK, Tupps C, Bino S, Chipoya M, et al
    Investments in seasonal influenza vaccination programs pack a punch for pandemic preparedness.
    Vaccine. 2026;92:129098.
    PubMed         Abstract available
    
    
27. TRAN S, McClymont E, Blitz S, Barrett J, et al
    Self-reported reactogenicity after COVID-19 vaccination with and without influenza vaccine coadministration during pregnancy in Canada.
    Vaccine. 2026;92:129122.
    PubMed         Abstract available
    
    
28. MARIA DA, Martins IM, Porto GPM, Villas-Boas IM, et al
    Safety, humoral and cellular immune responses to a pre-pandemic adjuvanted influenza A (H5N8) vaccine.
    Vaccine. 2026;92:129049.
    PubMed         Abstract available
    
    
29. ZHENG Y, Qiao B, Gao Z, Zhang X, et al
    Development of a subunit vaccine candidate (RBD-HA trimer) provides dual protection against multi-subtype avian influenza viruses and QX-type infectious bronchitis virus.
    Vaccine. 2026;92:129121.
    PubMed         Abstract available
    
    
30. KORNUTA CA, Zhou G, Kane KP, Vliagoftis H, et al
    Mucosal adjuvant activity of a PAR-2-activating peptide enhances lymph node immune cell recruitment and promotes immune cell activation in a prime-boost influenza vaccination model.
    Vaccine. 2026;92:129110.
    PubMed         Abstract available
    
    

    
    Virology

31. BROGAARD L, Laybourn HA, Kristensen C, Welner S, et al
    Site-specific microRNA responses in lungs of pigs depend on the host-adaptation of H1N1 influenza A virus.
    Virology. 2026;624:111053.
    PubMed         Abstract available
    
    
32. SEKINE W, Kamiki H, Ishida H, Matsugo H, et al
    HA1-T138A and HA1-Q226L substitutions in H3N2 canine influenza virus contribute to binding to human-type alpha2,6-linked sialic acid receptors.
    Virology. 2026;625:111071.
    PubMed         Abstract available
    
    
33. OLDENSAND F, Rafati N, Van Hoef V, Lundkvist A, et al
    Single-cell transcriptomic landscape of avian influenza H9N2 virus infection in human and chicken cells.
    Virology. 2026;625:111070.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum